Borut Jamnik

SID banka dd operates as a development and export bank. It offers financing, insurance, and investment services. The company was founded in 1992 and is headquartered in Ljubljana, Slovenia.

SID banka dd operates as a development and export bank. It offers financing, insurance, and investment services. The company was founded in 1992 and is headquartered in Ljubljana, Slovenia.

SID banka dd operates as a development and export bank. It offers financing, insurance, and investment services. The company was founded in 1992 and is headquartered in Ljubljana, Slovenia.

SID banka dd operates as a development and export bank. It offers financing, insurance, and investment services. The company was founded in 1992 and is headquartered in Ljubljana, Slovenia.

SID banka dd operates as a development and export bank. It offers financing, insurance, and investment services. The company was founded in 1992 and is headquartered in Ljubljana, Slovenia.

SID banka dd operates as a development and export bank. It offers financing, insurance, and investment services. The company was founded in 1992 and is headquartered in Ljubljana, Slovenia.

SID banka dd operates as a development and export bank. It offers financing, insurance, and investment services. The company was founded in 1992 and is headquartered in Ljubljana, Slovenia.

SID banka dd operates as a development and export bank. It offers financing, insurance, and investment services. The company was founded in 1992 and is headquartered in Ljubljana, Slovenia.

Part of KRKA dd, KRKA Farmaceutici Milano SRL is a leading Italian generic pharmaceutical company with nearly 70 years of experience. The company is based in Milan, Italy. We use modern technologies and our own analytical methods to develop and produce new pharmaceutical forms and strengths. Every day more than 12,000 employees work on the quality, innovation and development of pharmaceutical products. By focusing on patient needs and requirements, our innovations facilitate treatment and improve patient adherence and therapy outcomes. The company was founded in 1954. Jože Colaric has been the CEO of the company since 2004.

Modra zavarovalnica, d. d. (Modra) is an insurance management firm headquartered in Ljubljana, Slovenia. The firm is a subsidiary of government-owned Kapitalska druzba dd. Modra was founded in 2011 to create affordable pension insurance and other financial solutions to increase the social security of the individual in all stages of life.

SID banka dd operates as a development and export bank. It offers financing, insurance, and investment services. The company was founded in 1992 and is headquartered in Ljubljana, Slovenia.

SID banka dd operates as a development and export bank. It offers financing, insurance, and investment services. The company was founded in 1992 and is headquartered in Ljubljana, Slovenia.

Part of KRKA dd, KRKA Farmaceutici Milano SRL is a leading Italian generic pharmaceutical company with nearly 70 years of experience. The company is based in Milan, Italy. We use modern technologies and our own analytical methods to develop and produce new pharmaceutical forms and strengths. Every day more than 12,000 employees work on the quality, innovation and development of pharmaceutical products. By focusing on patient needs and requirements, our innovations facilitate treatment and improve patient adherence and therapy outcomes. The company was founded in 1954. Jože Colaric has been the CEO of the company since 2004.

Modra zavarovalnica, d. d. (Modra) is an insurance management firm headquartered in Ljubljana, Slovenia. The firm is a subsidiary of government-owned Kapitalska druzba dd. Modra was founded in 2011 to create affordable pension insurance and other financial solutions to increase the social security of the individual in all stages of life.

Part of KRKA dd, KRKA Farmaceutici Milano SRL is a leading Italian generic pharmaceutical company with nearly 70 years of experience. The company is based in Milan, Italy. We use modern technologies and our own analytical methods to develop and produce new pharmaceutical forms and strengths. Every day more than 12,000 employees work on the quality, innovation and development of pharmaceutical products. By focusing on patient needs and requirements, our innovations facilitate treatment and improve patient adherence and therapy outcomes. The company was founded in 1954. Jože Colaric has been the CEO of the company since 2004.

Part of KRKA dd, KRKA Farmaceutici Milano SRL is a leading Italian generic pharmaceutical company with nearly 70 years of experience. The company is based in Milan, Italy. We use modern technologies and our own analytical methods to develop and produce new pharmaceutical forms and strengths. Every day more than 12,000 employees work on the quality, innovation and development of pharmaceutical products. By focusing on patient needs and requirements, our innovations facilitate treatment and improve patient adherence and therapy outcomes. The company was founded in 1954. Jože Colaric has been the CEO of the company since 2004.

Part of KRKA dd, KRKA Farmaceutici Milano SRL is a leading Italian generic pharmaceutical company with nearly 70 years of experience. The company is based in Milan, Italy. We use modern technologies and our own analytical methods to develop and produce new pharmaceutical forms and strengths. Every day more than 12,000 employees work on the quality, innovation and development of pharmaceutical products. By focusing on patient needs and requirements, our innovations facilitate treatment and improve patient adherence and therapy outcomes. The company was founded in 1954. Jože Colaric has been the CEO of the company since 2004.

Part of KRKA dd, KRKA Farmaceutici Milano SRL is a leading Italian generic pharmaceutical company with nearly 70 years of experience. The company is based in Milan, Italy. We use modern technologies and our own analytical methods to develop and produce new pharmaceutical forms and strengths. Every day more than 12,000 employees work on the quality, innovation and development of pharmaceutical products. By focusing on patient needs and requirements, our innovations facilitate treatment and improve patient adherence and therapy outcomes. The company was founded in 1954. Jože Colaric has been the CEO of the company since 2004.